Rapamycin Ameliorates Experimental Autoimmune Myocarditis

  • Maeda Kayo
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine
  • Shioi Tetsuo
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine
  • Kosugi Rie
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine
  • Yoshida Yuki
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine
  • Takahashi Keiko
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine
  • Machida Yoji
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine
  • Izumi Tohru
    Department of Internal Medicine and Cardiology, Kitasato University School of Medicine

この論文をさがす

抄録

Myosin-induced autoimmune myocarditis in rats is a model of human dilated cardiomyopathy. Rapamycin is a potent immunosuppressant and specifically inactivates the mammalian target of rapamycin (mTOR).<br> To examine the role of mTOR in autoimmune myocarditis, we administered rapamycin to rats immunized with cardiac myosin. Phosphorylation of p70 ribosomal S6 kinase 1 (S6K1), a target of mTOR, was increased by 6.9 fold in the heart tissue of myosin immunized rats. Rapamycin (2 mg/kg/day) completely suppressed S6K1 and S6 phosphorylation. The amount of interleukin-1β, interferon-γ, interleukin-2, or tumor necrosis factor-α mRNA in the heart tissue was markedly increased in myosin-immunized rats, and rapamycin significantly attenuated the cytokine gene expressions. Rapamycin improved the survival of the rats and preserved cardiac function. The plasma level of brain natriuretic peptide increased by 4.7 fold in myosin-immunized rats, and rapamycin attenuated the increase in plasma brain natriuretic peptide. The heart weight/tibial length ratio of vehicle-treated myosin-immunized rats was increased by 1.81 ± 0.06 fold compared with vehicle-treated unimmunized rats, and rapamycin suppressed the increase in heart weight. Rapamycin decreased the cellular infiltration and fibrosis of the myocardium. The amount of phosphorylated S6 was increased in the infiltrating mononuclear cells in vehicle-treated myosin-immunized rats.<br> Rapamycin significantly ameliorated myocardial injury and preserved cardiac function in a rat model of autoimmune myocarditis. <br>

収録刊行物

  • International Heart Journal

    International Heart Journal 46 (3), 513-530, 2005

    一般社団法人 インターナショナル・ハート・ジャーナル刊行会

参考文献 (39)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ